Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 5, 2019
Atypical Chemokine Receptor 1 (<i>DARC/ACKR1</i>) in Breast Tumors Is Associated with Survival, Circulating Chemokines, Tumor-Infiltrating Immune Cells, and African AncestryBrittany D Jenkins, Rachel N Martini, Rupali Hire, et al.
Psycho-Oncology|May 22, 2023
Psychosocial well-being during the COVID-19 pandemic among women with and without breast cancerLaura C Pinheiro, Genevieve A Fasano, Anjile An, et al.
American Journal of Surgery|May 31, 2022
Impact of the COVID-19 breast cancer screening hiatus on clinical stage and racial disparities in New York CityGenevieve A Fasano, Solange Bayard, Rulla Tamimi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2020
Racial Differences in the Association Between Luminal Master Regulator Gene Expression Levels and Breast Cancer SurvivalJung S Byun, Sandeep K Singhal, Samson Park, et al.
Dysphagia|August 2, 2008
What information do clinicians use in recommending oral versus nonoral feeding in oropharyngeal dysphagic patients?Jeri A Logemann, Alfred Rademaker, Barbara Roa Pauloski, et al.
Biorxiv : the Preprint Server for Biology|December 11, 2023
Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatmentFlorencia P Madorsky Rowdo, Gu Xiao, Galina F Khramtsova, et al.
Cancer Letters|January 10, 2024
Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatmentFlorencia P Madorsky Rowdo, Gu Xiao, Galina F Khramtsova, et al.
The Plant Cell|September 8, 2016
Morphogenic Regulators <i>Baby boom</i> and <i>Wuschel</i> Improve Monocot TransformationKeith Lowe, Emily Wu, Ning Wang, et al.
Pageof 7